Tumor‐secreted products repress B‐cell lymphopoiesis in a murine model of breast cancer

Growing cancers are known to modify immune responses through suppressive mechanisms manifested within the local tumor microenvironment. Accumulating evidence indicates that secreted tumor products can also influence on distant immunological compartments, including myelopoiesis in the bone marrow. However, it is unknown if a similar effect can occur to regulate B‐cell lymphopoiesis in breast cancer. Examining the MMTV‐PyMT murine model of breast cancer, we show a complete block in bone marrow B‐cell lymphopoiesis, which is dependent on tumor burden. We also observed an increase in the total number of splenic B cells and an elevated frequency of marginal zone B cells. By using in vitro assays of B‐cell lymphopoiesis, we show that tumor‐secreted molecules directly inhibit B‐cell progenitor proliferation and favor maturation. These data demonstrate a profound sensitivity of B‐cell lymphopoiesis to the accumulation of ectopically produced molecules during tumor growth in PyMT.

[1]  H. Dombret,et al.  Addition of Rituximab Improves the Outcome of Adult Patients with CD20-Positive, Ph-Negative, B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Graall-R 2005 Study , 2015 .

[2]  L. Zitvogel,et al.  Natural and therapy-induced immunosurveillance in breast cancer , 2015, Nature Medicine.

[3]  Clinton S. Robbins,et al.  Inflammation rapidly reorganizes mouse bone marrow B cells and their environment in conjunction with early IgM responses. , 2015, Blood.

[4]  A. Sica,et al.  RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis. , 2015, Cancer cell.

[5]  E. Passegué,et al.  Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils , 2015, Proceedings of the National Academy of Sciences.

[6]  Markus G. Manz,et al.  Emergency granulopoiesis , 2014, Nature Reviews Immunology.

[7]  B. Nelson,et al.  Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cells. , 2013, Cancer research.

[8]  G. Coukos,et al.  Deciphering and reversing tumor immune suppression. , 2013, Immunity.

[9]  O. Winqvist,et al.  Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies , 2013, The Journal of Immunology.

[10]  R. Xavier,et al.  Angiotensin II drives the production of tumor-promoting macrophages. , 2013, Immunity.

[11]  Denise G. Lanza,et al.  Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model , 2012, Tumor Biology.

[12]  B. Nelson,et al.  CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes , 2010, The Journal of Immunology.

[13]  K. Flaherty,et al.  Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers , 2009, Clinical Cancer Research.

[14]  G. Kelsoe,et al.  Effects of acute and chronic inflammation on B-cell development and differentiation. , 2009, The Journal of investigative dermatology.

[15]  M. Caligiuri,et al.  Tumor Growth Decreases NK and B Cells as well as Common Lymphoid Progenitor , 2008, PloS one.

[16]  M. Caligiuri,et al.  Tumor growth impedes natural-killer-cell maturation in the bone marrow. , 2006, Blood.

[17]  C. Paige,et al.  IL-7: a key regulator of B lymphopoiesis. , 2006, Seminars in immunology.

[18]  G. Kelsoe,et al.  Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow , 2005, The Journal of experimental medicine.

[19]  G. Kelsoe,et al.  Inflammation Controls B Lymphopoiesis by Regulating Chemokine CXCL12 Expression , 2004, The Journal of experimental medicine.

[20]  Jeffrey W Pollard,et al.  Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. , 2003, The American journal of pathology.

[21]  S. Akira,et al.  Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Frey,et al.  Mice Bearing Late-Stage Tumors Have Normal Functional Systemic T Cell Responses In Vitro and In Vivo1 , 2000, The Journal of Immunology.

[23]  T. Honjo,et al.  Induction and regulation of immunoglobulin expression in a murine pre-B cell line, 70Z/3. I. Cell cycle-associated induction of sIgM expression and kappa-chain synthesis in 70Z/3 cells by LPS stimulation. , 1980, Journal of immunology.

[24]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.